BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis | MicrobiomeTrials← Back to trialsNCT07237308
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-07-14Est. Completion: 2029-07
Enrollment target: 586 participants Locations- Yonsei University College of Medicine, Seoul, South Korea
Other microbiome trials you might be interested in
Stroke, Acute
The purpose of this study is to compare two strategies for treating adults with suspected large vessel occlusion stroke …
New Haven, United StatesEst. completion Apr 30, 2028
Aortic Valve Stenosis
Transcatheter aortic valve implantation (TAVI) is a key-hole technique to replace an aortic heart valve that is narrowed…
Aarhus, DenmarkEst. completion Dec 2027
The goal of this randomized controlled clinical trial is to evaluate the effects of connective tissue massage (CTM) adde…
Konya, Turkey (Türkiye)Est. completion Dec 1, 2027